Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
12/23/2003 | US6667169 Polypeptides having acid phosphatase activity and nucleic acids encoding same |
12/23/2003 | US6667168 PAK4, a novel gene encoding a serine/threonine kinase |
12/23/2003 | US6667167 Storage-stable liquid formulation comprising a laccase |
12/23/2003 | US6667166 Preparing pantothenic acid; obtain genetically engineered bacteria, culture, express phosphofructokinase, recover pantothenic acid |
12/23/2003 | US6667165 Method and compositions for reversible inhibition of thermostable polymerases |
12/23/2003 | US6667163 Genetic engineering |
12/23/2003 | US6667152 Method for selective inactivation of viral replication |
12/23/2003 | US6667066 Multi-enzyme product with glucoamylase, proteolytic and xylanase activities and method for producing same by solid state fermentation of wheat bran with Aspergillus niger |
12/23/2003 | US6667065 Non-maltogenic exoamylases and their use in retarding retrogradation of starch |
12/23/2003 | US6667040 Bovine footrot treatment and prevention |
12/23/2003 | US6667037 Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof |
12/23/2003 | CA2087342C Serine protease variants having peptide ligase activity |
12/18/2003 | WO2003104475A2 Atm related kinase atx, nucleic acids encoding same and methods of use |
12/18/2003 | WO2003104470A2 Retrons for gene targeting |
12/18/2003 | WO2003104454A1 Novel oxidase |
12/18/2003 | WO2003104446A1 Novel acylase gene |
12/18/2003 | WO2003104445A1 Aldehyde dehydrogenase |
12/18/2003 | WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
12/18/2003 | WO2003104422A2 Mahoganoid polypeptides, and related compositions and methods |
12/18/2003 | WO2003104417A2 Nicking endonucleases |
12/18/2003 | WO2003104410A2 Enzymes |
12/18/2003 | WO2003104408A2 Commercial production of recombinant manganese-dependent peroxidase in plants |
12/18/2003 | WO2003104403A2 Method of controling acetylation of metabolic enzymes |
12/18/2003 | WO2003104394A2 Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon |
12/18/2003 | WO2003104390A2 Adamts nucleic acids and proteins |
12/18/2003 | WO2003104382A1 Improved method for the prevention or reduction of haze in beverages |
12/18/2003 | WO2003104271A1 Enzymes which degrade thio compounds, and methods of use thereof |
12/18/2003 | WO2003103705A1 Metalloproteinase inhibitors |
12/18/2003 | WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance |
12/18/2003 | WO2003103593A2 Secretases related to alzheimer's dementia |
12/18/2003 | WO2003103578A2 Bacteriophage and enzymes lytic to salmonellae |
12/18/2003 | WO2003103577A2 Novel recombinant anticoagulant proteins |
12/18/2003 | WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
12/18/2003 | WO2003103475A2 Prevention and reduction of blood loss |
12/18/2003 | WO2003093436A3 Treatment for phenylketonuria |
12/18/2003 | WO2003089461A3 Purified dutpase from helicobacter pylori |
12/18/2003 | WO2003078640A3 Recombinant drug-sensitive vaccinia virus as smallpox vaccine |
12/18/2003 | WO2003074673A3 Lgals as modifiers of the chk pathway and methods of use |
12/18/2003 | WO2003074068A3 Use of soluble fgl2 as an immunosuppressant |
12/18/2003 | WO2003073839A3 Expression of lysosomal enzymes in plant seeds |
12/18/2003 | WO2003070928B1 Hydrolysis of lactose with immobilised thermoresistant lactase and the production method thereof |
12/18/2003 | WO2003066867A3 Genetically engineered phic31-integrase genes |
12/18/2003 | WO2003066847A3 Phytase variants |
12/18/2003 | WO2003057886A3 Detection of mutations |
12/18/2003 | WO2003054181A3 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
12/18/2003 | WO2003052054A3 Bgl5 beta-glucosidase and nucleic acids encoding the same |
12/18/2003 | WO2003046131A3 Dnmt3l-related cloning and reproductive methods |
12/18/2003 | WO2003042380A3 Materials and methods for reducing oxalate concentrations in fluids |
12/18/2003 | WO2003038111A3 Phytase enzymes, nucleic acid sequences encoding phytase enzymes and vectors and host cells incorporating same |
12/18/2003 | WO2003031608A3 Mutated abl kinase domains |
12/18/2003 | WO2003031606A3 Crystal structure of an aurora kinase catalytic domain, and use thereof |
12/18/2003 | WO2003029437A3 Secreted proteins |
12/18/2003 | WO2003026389A3 Manipulation of plant polysaccharide synthases |
12/18/2003 | WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
12/18/2003 | WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia |
12/18/2003 | WO2003013225A3 Wheat plants having increased resistance to imidazolinone herbicides |
12/18/2003 | WO2003004679A3 Enoyl-acp reductases |
12/18/2003 | WO2003004598A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
12/18/2003 | WO2003000903A3 Regulation of human nek-like serine/threonine protein kinase |
12/18/2003 | WO2002099095A3 Improved isoprenoid production |
12/18/2003 | WO2002090543A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein |
12/18/2003 | WO2002083030A3 Bifunctional energy-reversible acyl-compositions |
12/18/2003 | WO2002082087A3 Diagnosis and treatment of enterococcus faecium related disease |
12/18/2003 | WO2002081668A3 Desaturase genes and uses thereof |
12/18/2003 | WO2002079388A3 Modulation of mhc class i antigen presentation |
12/18/2003 | WO2002070649A3 Epimerase gene and use thereof |
12/18/2003 | WO2002062962A3 60491, a novel human acyltransferase family member and uses thereof |
12/18/2003 | WO2002042443A3 Use of modulators of eukaryotic signal transduction pathways for the treatment of helicobacter infections |
12/18/2003 | WO2002036759A3 Polynucleotides encoding human meltrin beta (adam19) metalloendopeptidases |
12/18/2003 | WO2000065025A3 Dna molecules encoding human endothelin converting enzyme 3 |
12/18/2003 | US20030233679 Methods for controlling gibberellin levels |
12/18/2003 | US20030233678 Pre- and post-harvest inhibition of remobilisation of storage compounds |
12/18/2003 | US20030233672 Comprises zinc finger protein modulating which binds to gamma tocopherol methyltransferase (GMT) and modulates alpha-tocopherol content in plant organs |
12/18/2003 | US20030233668 Comprises peptides associated with purinergic receptors for treating neurodegenerative, psychological and nervous system disorders; mimetics |
12/18/2003 | US20030232975 Comprises nucleotide sequences coding polypeptides for diagnosing, preventing and treating cancer |
12/18/2003 | US20030232967 Method for preparation of microarrays for screening of crystal growth conditions |
12/18/2003 | US20030232816 Benzimidazole derivatives |
12/18/2003 | US20030232782 Method of controlling acetylation of metabolic enzymes |
12/18/2003 | US20030232777 An oligonucleotides or polynucleotides targeted to hybridization with the nucleic acids, gene expression inhibition, treating angiogenic diseases, metabolic disease, neurodegenerative disease, cancer, inflammation; gene therapy |
12/18/2003 | US20030232775 Antisense modulation of phosphatidylinositol-4-phosphate 5-kinase, type II beta expression |
12/18/2003 | US20030232419 Molecules interacting with CASL (MICAL) polynucleotides, polypeptides, and methods of using the same |
12/18/2003 | US20030232418 Comprises pyrroloquinoline quinone dependent glucose dehydrogenase (PQQGDH) having decreased activity on disaccharides; measurement of glucose in blood sample; food analysis |
12/18/2003 | US20030232416 Synthesis of synthons for the manufacture of bioactive compounds |
12/18/2003 | US20030232415 Comprises nucleotide sequences coding protein associated with avermectin biosynthesis (AVEC); antibiotic preparation; veterinary medicine |
12/18/2003 | US20030232414 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
12/18/2003 | US20030232413 Transformed fungi for production of recombinant proteins |
12/18/2003 | US20030232410 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
12/18/2003 | US20030232409 Genetically engineered swine cell for use as models in cancer treatment and diagnosis |
12/18/2003 | US20030232408 Comprises serine/threonine kinase for use as diagnostic tool in mammalian therapeutics and diagnostics; enzyme inhibitors; antitumor/antiinflammatory agents |
12/18/2003 | US20030232404 Comprises heat resistant beetle luciferase with increased half-life for use as diagnostic tool in genetic engineering |
12/18/2003 | US20030232389 NMR structure of the peptidic urokinase type plasminogen activator antagonist has been solved to identify design strategies for peptidomimetics that interfere with the binding of urokinase type plasminogen activator with its receptor |
12/18/2003 | US20030232373 Pth (polynucleotides and polypeptides of the peptidyl-tRNA hydrolases); utilizing pth polypeptides to screen for antibacterial compounds |
12/18/2003 | US20030232370 Glucose sensor and uses thereof |
12/18/2003 | US20030232369 Useful in structural homology deduction, in developing and screening agents that affect the activity of eukaryotic RNA polymerase, and in designing modified forms of eukaryotic RNA polymerase |
12/18/2003 | US20030232363 Fatty acid transport proteins |
12/18/2003 | US20030232357 A heat-stable enzyme having a DNA helicase activity, and a structure-specific endonuclease activity; obtained by cloning a gene encoding the enzyme from chromosomal DNA of a a sulfur-metabolizing thermophilic archaebacteria |
12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
12/18/2003 | US20030232337 Detection of Staphylococcus spp. |
12/18/2003 | US20030232054 Novel nucleic acids and polypeptides |
12/18/2003 | US20030232041 For use in food and feeds |